Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Non - Depolarizing Blockade: Ion channel agonists. Competitively block the ACh binding sites. Actions can be reversed by an excess of ACh due to competitive nature of blockade Non - Depolarizing Neuromuscular Blockers Drugs 1.Tubocurarine (curare) Description Tx Application Paralytic agent (80 – 120 mins). No initial excitation, only blockade resulting in paralysis. Muscle relaxant & surgical adjuvant. S/E Poisoning – treatable with AchE inhibitors 2. Histamine release – be careful with asthmatics. Order of paralysis eye, jaw, throat & neck, appendages, abdominal muscles, intercostals muscles and diaphragm. 3. Synergism with antibiotics (Streptomycin, and Tetra’s) a. chelates Ca ~>paralysis b. prolonged duration of action Have bifunctional 3 and 4 N, and a Benzylisoquinoline group. (BenzIsoQ) 2. Cisatracurium (1R cis 1’R cis) Duration is 30 – 40 mins. C/I or Precaution 1. Excreted in urine – May have extended duration of action in patients with renal insufficiency. Better choice for patients with reduced renal function I don’t know!!! But the drug is degraded thru non –enzymatic Does not require Liver or Kidney for cessation of action. 10 possible isomers for 4 chiral centers 3. Pancuronium Has two 4’nary ammonium. Duration is 120-180 mins 4. Vecuronium Can produce active metabolite at C3 alcohol. Has 3 and 4N 5. Rocuronium No ester grp at C3hydroxyl grp. Ammonio steroids: steroid backbone provides as a spacer. Greater selectivity for Nm over Nn r/c. No histamine release, preferred for asthmatics I don’t know!! But drug is renally eliminated Long acting: 120-180 mins Same as 3 Same as 3 Don’t know!!! Metabolized in the liver Intermediate acting: 60-90 mins. Same as 3 Same as 3 Same as 4 Intermediate acting: 30-69 mins. Drugs Description 1.Mecamylamine Very limited use! Structure does not fit SAR Some selectivity for Nn over Nm r/c, adjust dose to affect only Nn r/c Control BP and bleeding during surgery. Competitively block the channel and ACh binding sites. Tested for off-label CNS neuroprotective effects. Non - Depolarizing Ganglionic Blockers Axn can be reversed by an excess ACh due to competitive nature of blockade Tx Application S/E Decrease BP C/I or Precaution Hypotension? - I don’t know. Depolarizing Blockade: Ion channel agonists. Opening the ion channel causes an initial depolarization of the post-ganglionic neuron (or the adrenal medulla). Persistant stimulation induces Phase I followed by Phase II blockade. Blockade can NOT be reversed by excess ACh (must wait for resensitization of the ion channels to occur over time. Phase I blockade: ion channel remains open in the presence of a depolarizing blocker and repolarization can’t occur. Phase II blockade: ion channels closes, repolarization of the cell occurs, but the Nn r/c is desensitized and unable to respond for further stimulation for a time ~ 5min. Depolarizing Neuromuscular Blockers Drugs 1.Succinylcholine Nm r/c selective. Each half is ACh: bifunctional. Rapidly hydrolyzed by ButyrlChE and circulating plasma pseudocholinesterases, thus short duration of action. Description Opens the ion channel and causes and initial depolarization of the muscle cell leading to contraction and twitching for ~ 1 min. Tx Application Short duration effect is useful where short term paralysis is required: Electroshock therapy Setting fractures and dislocations Endotracheal intubations. Persistent stimulation renders the muscle cells incapable of repolarization and blockade ensues Phase I and Phase II blockade. S/E May have muscle pain and soreness from initial twitching. Hyperkalemia (release of K into bloodstream). MALIGNANT HYPERTHERMIA (MH) – if used in conjunction with inhalational anaesthetics. Following the contraction, a short term, ~5min, paralysis. C/I or Precaution There is no Chemical antidote for a depolarizing blocker. Duration of action may be dangerously extended with liver disease or genetic defects resulting in low levels of circulating cholinesterase. Hyperkalemia is problematic for patients in electrolyte imbalance or taking digitalis. MH – dangerously increased body Temp. Treatment includes cooling, heat dissipation, Oxygen admin, control of acidosis and …… Dantrolene, which blocks calcium release from SR to control hypermetabolism leading to hyperthermia. Depolarizing Ganglionic Blocker Drugs Description 1. Nicotine Initial excitation followed by persistent blockade. Effect is release of EPI following excitation of Adrenal medulla Nn r/c Some selectivity for Nn over Nm r/c. In high doses, effects in Nm r/c are muscle twitching and blockade. 2. Varenicline Nicotinic partial agonist at (alpha4)2(beta2)3 and full agonist at (alpha7)5 nicotinic r/c Tx Application Smoking cessation patches, analgesics. GI protective effects to reduce inflammation in ulcerative colitis As a partial agonist: reduce withdrawal symptoms without activating dependency p/w. S/E Epi will Increase HR, BP Special effects of nicotine: activation followed by depolarization of: Nn pain afferent r/c. Nn r/c on chemosensory neurons; increase respiration. Nn r/c on stretch sensory neurons: reflex vomiting. Irritability, insomnia, restlessness. Aches, pains. Constipation, increased appetite, sugar cravings. C/I or Precaution Addictive properties based on CNS effect; NO antidote, induce vomiting Ganglionic Signaling Blockade: Ganglionic Signaling: Activation of Nn r/c by ACh is rapid, excitatory and REQUIRED for development of an action potential (AP) in post synaptic cell. Activation of other receptors or input from other neurons in the ganglia may POTENTIATE or INHIBIT the primary effect of Nn activation, but have NO EFFECT ALONE. Special summation in the ganglia is THE SUMMING OF ALL POTENTIATING AND INHIBITORY INPUTS modifying the Nn activated EPSP (excitatory post synaptic potential), and determining whether a threshold is reached whereby an AP is generated down the post ganglionic neuron. Ganglionic Blockade Agents that activate or inhibit Nn signaling in the ganglia (Nicotinic agonists and antagonists) BOTH ULTIMATELY PRODUCE BLOCKADE. Primary actions are variable depend on: PREDOMINANT TONE OF THE ORGAN, AGE, SYMPATHETIC TONE, ETC. SITE BLOOD VESSELS BLADDER & GI SPHINCTERS HEART EYE GI TRACT URINARY BLADDER SALIVARY GLANDS PRDOMINANT TONE SYMPA SYMPA PARA PARA PARA PARA PARA PRIMARY EFFECT OF GANGLIONIC BLOCKADE HYPOTENSION ??? TACHYCARDIA MYDRIASIS, BLURRED VISION DECREASED MOTILITY URINARY RETENTION DRY MOUTH Neuromuscular Signaling Blockade: Neuromuscular signaling – Nm r/c at the muscle enplate activated by ACh released from somatic nerves Both non-depolarizing and depolarizing neuromuscular blockers exists Some neuromuscular blockers are Nm selective because they can NOT cross into the ganglionic space.